OKYO Pharma Limited Research and Development Expense
OKYO Pharma Limited (OKYO) reported Research and Development Expense of $2.25 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-07-18
| Period end | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|
| 2025-03-31 | $2.25M 20-F · filed 2025-07-18 | |
| 2024-03-31 | $8.24M 20-F · filed 2025-07-18 | |
| 2023-03-31 | $6.34M 20-F · filed 2025-07-18 | |
| 2022-03-31 | $1.61M 20-F · filed 2024-08-13 | $1.30M 20-F · filed 2022-08-15 |
| 2021-03-31 | $348.35K 20-F · filed 2023-08-15 | $173.82K 20-F · filed 2022-08-15 |
| 2020-03-31 | $518.10K 20-F · filed 2022-08-15 |